• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 831

Substance: Bacillus subtilis DE111
Intended Use: For use as an ingredient in baked goods and baking mixes; alcoholic beverages; beverages and beverage bases; breakfast cereals; chewing gum; coffee and tea; condiments and relishes; confections and frostings; dairy product analogs; fats and oils; fruit juices; frozen dairy desserts and mixes; fruit and water ices; gelatins, puddings, and fillings; grain products and pastas; hard candy and cough drops; herbs, seeds, spices, seasonings, blends, extracts, and flavorings; jams and jellies; milk; milk products; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soft candy; soups and soup mixes*; sugar; and sweet sauces, toppings, and syrups at a level intended to provide no greater than 1 x 1010 CFU/serving in foods intended for adults and no greater than 1 x 109 CFU/serving in foods intended for children aged 2-12. Intended for use in infant formula at a level no greater than 2 X 108 CFU/100 ml infant formula.
Basis: Scientific procedures
Notifier: Deerland Probiotics and Enzymes
3800 Cobb International Blvd
Kennesaw, GA 30152
GRAS Notice (releasable information): GRN 831 (in PDF) (6.4 MB)
Date of closure: Oct 7, 2019
FDA's Letter: FDA has no questions (in PDF) (73 KB)